CNBC 快讯 4月16日 11:53 礼来减肥药Foundayo心血管试验成功：GLP-1赛道从减重疗效迈向心血管获益金标准认定 Lilly's obesity pill helps reduce cardiovascular risks in late-stage trial In the study of more than 2,700 adults, patients taking Foundayo had a 16% lower risk of heart attack, stroke or cardiov… FG 100 读报告 →